A charming chat: part 3 ENROLL NOW in UnitedHealth Group Clinical Trial
Channel: The Doctor Weighs In
Date: 2020-06-08

One area of Covid 19 treatment that has been successful in the past, but not leveraged as much is adoptive immunity of transferring sensitized serum to patients who are just starting to develop symptoms with the serum of patients who have overcome the disease. 

In this interview, we talk with Chief Medical Officer (CMO) of UnitedHealth Group, Dr. Migliori to discuss their collaboration with the Mayo Clinic for a clinical trial that has recruited over 27,000 patients. 

This enormous collaboration with UnitedHealthcare involves over 7,000 doctors, 2400 participating centers including John Hopkins, Mt. Sinai and several others including local community hospitals. 

"With testing, isolation, contact tracing and quaratine. This thing (Covdid19) doesn't have a chance if it comes back a second time" - Dr. Migliori

This is final video in a three part series. 

You can also check out the article on thedoctorweighsin.com. To enroll now, visit: https://www.uscovidplasma.org/

Help stop the spread of the coronavirus.